Fu, Y., Duan, W., Xu, R., & Chen, J. (2023). Conversion therapy with immunotherapy plus chemotherapy achieves a pathological complete response in stage IIIC NSCLC. Frontiers Media S.A.
Chicago Style (17th ed.) CitationFu, Yu, Weichen Duan, Ran Xu, and Jiajia Chen. Conversion Therapy with Immunotherapy Plus Chemotherapy Achieves a Pathological Complete Response in Stage IIIC NSCLC. Frontiers Media S.A, 2023.
MLA (9th ed.) CitationFu, Yu, et al. Conversion Therapy with Immunotherapy Plus Chemotherapy Achieves a Pathological Complete Response in Stage IIIC NSCLC. Frontiers Media S.A, 2023.
Warning: These citations may not always be 100% accurate.